- Home
- MDGL vs MAT Comparison
MDGL vs MAT Comparison
Compare MDGL & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- MAT
- Stock Information
- Founded
- MDGL 2011
- MAT 1945
- Country
- MDGL United States
- MAT United States
- Employees
- MDGL N/A
- MAT N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- MAT Recreational Games/Products/Toys
- Sector
- MDGL Health Care
- MAT Consumer Discretionary
- Exchange
- MDGL Nasdaq
- MAT Nasdaq
- Market Cap
- MDGL 6.1B
- MAT 5.9B
- IPO Year
- MDGL N/A
- MAT N/A
- Fundamental
- Price
- MDGL $440.75
- MAT $17.33
- Analyst Decision
- MDGL Strong Buy
- MAT Strong Buy
- Analyst Count
- MDGL 10
- MAT 9
- Target Price
- MDGL $474.67
- MAT $24.78
- AVG Volume (30 Days)
- MDGL 341.0K
- MAT 2.7M
- Earning Date
- MDGL 10-30-2025
- MAT 10-22-2025
- Dividend Yield
- MDGL N/A
- MAT N/A
- EPS Growth
- MDGL N/A
- MAT 74.53
- EPS
- MDGL N/A
- MAT 1.58
- Revenue
- MDGL $515,547,000.00
- MAT $5,335,500,000.00
- Revenue This Year
- MDGL $394.12
- MAT $2.57
- Revenue Next Year
- MDGL $57.74
- MAT $2.72
- P/E Ratio
- MDGL N/A
- MAT $10.96
- Revenue Growth
- MDGL 3421.98
- MAT N/A
- 52 Week Low
- MDGL $200.63
- MAT $13.95
- 52 Week High
- MDGL $457.16
- MAT $22.07
- Technical
- Relative Strength Index (RSI)
- MDGL 62.88
- MAT 37.94
- Support Level
- MDGL $415.53
- MAT $17.07
- Resistance Level
- MDGL $440.90
- MAT $17.55
- Average True Range (ATR)
- MDGL 14.27
- MAT 0.38
- MACD
- MDGL -4.71
- MAT -0.12
- Stochastic Oscillator
- MDGL 60.58
- MAT 12.94
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.